Class II Recall

Pharmacy Innovations

Product
GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 31%(V/V)/0.17%/0.00017% (10ML VIALS); GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 48.7%(W/V)/0.67%/0.00067% (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Reason
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Classification
Class II
Status
Terminated
Lot
t20221116@36 t20221117@11
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Pharmacy Innovations — Class II Recall | MedicineWatch US